Heliyon (Dec 2023)

Morbidity and mortality of acute heart failure patients stratified by mitral regurgitation in the Arabian Gulf: Observations from the Gulf acute heart failure registry (Gulf CARE)

  • Laura AlObaid,
  • Rajesh Rajan,
  • Mohammed Al Jarallah,
  • Raja Dashti,
  • Bassam Bulbanat,
  • Mustafa Ridha,
  • Kadhim Sulaiman,
  • Ibrahim Al-Zakwani,
  • Alawi A. Alsheikh-Ali,
  • Prashanth Panduranga,
  • Khalid F. AlHabib,
  • Jassim Al Suwaidi,
  • Wael Al-Mahmeed,
  • Hussam AlFaleh,
  • Abdelfatah Elasfar,
  • Ahmed Al-Motarreb,
  • Nooshin Bazargani,
  • Nidal Asaad,
  • Haitham Amin,
  • Zhanna Kobalava,
  • Peter A. Brady,
  • Georgiana Luisa Baca,
  • Ahmad Al-Saber

Journal volume & issue
Vol. 9, no. 12
p. e22175

Abstract

Read online

This study aimed to evaluate the clinical outcomes of patients with acute heart failure (AHF) stratified by mitral regurgitation (MR) in the Arabian Gulf. Patients from the Gulf CARE registry were identified from 47 hospitals in seven Arabian Gulf countries (Yemen, Oman, Kuwait, Qatar, Bahrain, the United Arab Emirates, and Saudi Arabia) from February to November 2012. The cohort was stratified into two groups based on the presence of MR. Univariable and multivariable statistical analyses were performed. The population cohort included 5005 consecutive patients presenting with AHF, of whom 1491 (29.8 %) had concomitant MR. The mean age of patients with AHF and concomitant MR was 59.2 ± 14.9 years, and 63.1 % (n = 2886) were male. A total of 58.6 % (n = 2683) had heart failure (HF) with reduced ejection fraction (EF) (HFrEF), 21.0 % (n = 961) had HF with mildly reduced EF (HFmrEF), and 20.4 % (n = 932) had HF with preserved EF (HFpEF). Patients with MR had a lower haemoglobin (Hb) level (12.4 vs. 12.7 g/dL; p < 0.001), and a higher prevalence of left atrial enlargement (80.2 % vs. 55.1 %; p < 0.001), cardiogenic shock (9.7 % vs. 7.3 %; p = 0.006) and atrial fibrillation (7.6 % vs. 5.6 %; p = 0.006), and HFrEF (71.0 % vs. 52.6 %; P < 0.001). Multivariable analysis demonstrated that MR was independently associated with increased all-cause mortality at 1-year and 3-month HF rehospitalization [1-year all-cause mortality, adjusted odds ratio (aOR), 1.40; 95 % confidence interval (Cl): 1.13–1.74; p = 0.002; 3-month HF rehospitalization, aOR, 1.26; 95 % Cl: 1.06–1.49; p = 0.009]. In an Arabian Gulf cohort with AHF, concomitant MR was associated with an increased risk of 1-year mortality and 3-months HF rehospitalization.

Keywords